Drug Shortage Report for NAPROXEN EC
Report ID | 49537 |
Drug Identification Number | 02350807 |
Brand name | NAPROXEN EC |
Common or Proper name | NAPROXEN EC TAB |
Company Name | SANIS HEALTH INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NAPROXEN |
Strength(s) | 500MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-06-15 |
Actual start date | 2018-06-06 |
Estimated end date | 2018-08-17 |
Actual end date | 2018-08-15 |
Shortage status | Resolved |
Updated date | 2018-08-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-08-16 | English | Compare |
v9 | 2018-08-15 | French | Compare |
v8 | 2018-08-15 | English | Compare |
v7 | 2018-07-30 | French | Compare |
v6 | 2018-07-30 | English | Compare |
v5 | 2018-06-07 | English | Compare |
v4 | 2018-06-06 | French | Compare |
v3 | 2018-06-06 | English | Compare |
v2 | 2018-05-16 | French | Compare |
v1 | 2018-05-16 | English | Compare |
Showing 1 to 10 of 10